Submission Details
| 510(k) Number | K954422 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 21, 1995 |
| Decision Date | December 15, 1995 |
| Days to Decision | 85 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Statement |
K954422 is an FDA 510(k) clearance for the PER-Q-CATH MID-LINE, a Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days (Class II — Special Controls, product code LJS), submitted by Gesco Intl., Inc. (Woburn, US). The FDA issued a Cleared decision on December 15, 1995, 85 days after receiving the submission on September 21, 1995. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5970.
| 510(k) Number | K954422 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 21, 1995 |
| Decision Date | December 15, 1995 |
| Days to Decision | 85 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Statement |
| Product Code | LJS — Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5970 |